Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II?
O'Donnell PH, Stadler WM. Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II? Clin Cancer Res. 2012 May 15; 18(10):2809-16.